South & Central America Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines,

South & Central America Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease (Avian Influenza, Salmonellosis, Marek's Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Newcastle Disease, and Others), Route Of Administration (Drinking water (D/W), Intramuscular (I/M), Subcutaneous (S/C), and Others), and End User (Poultry Farms, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)

The South & Central America poultry vaccines market was valued at US$ 298.35 million in 2023 and is expected to reach US$ 551.23 million by 2031; it is estimated to record a CAGR of 8.0% from 2023 to 2031.

Government Support for Mass Vaccination Drives and Innovative Schemes Fuel South & Central America Poultry Vaccines Market

Government worldwide is supportive against poultry vaccination with rising Global Burden of Disease (GBD). The support involves launching of mass vaccination schemes and several vaccination programs at vaccination centers or through door-step immunization services.

In 2024, in an effort to stop the spread of avian influenza, the Peruvian Poultry Association (APA) and the National Agrarian Health Service (Senasa) of Peru have implemented new rules. Directorial Resolution No. 0014-2024-Midagri-Senasa-DSA contains the regulations that require vaccination for specific poultry farms and health certification for the transportation of birds and products. A registered poultry health practitioner must supervise the immunization procedure. Senasa and the poultry industry are working together to improve the national poultry industry and guarantee the health of Peru's chicken population. This program is a part of that effort. Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years.

South & Central America Poultry Vaccines Market Overview

The South & Central America poultry vaccines market is segmented into Argentina, Brazil, and the Rest of South & Central America. Brazil is expected to hold the major market share in this region. The poultry vaccines market in this region is expected to grow rapidly due to expanding healthcare facilities, rising demand for protein-rich foods, and initiatives taken by various government agencies and animal associations.

South & Central America Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Poultry Vaccines Market Segmentation

The South & Central America poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the South & Central America poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the South & Central America poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the South & Central America poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the South & Central America poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The Newcastle disease segment held the largest market share in 2023.

In terms of route of administration, the South & Central America poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the South & Central America poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the South & Central America poultry vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the South & Central America poultry vaccines market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America poultry vaccines market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America poultry vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America poultry vaccines market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.